Gynecologic Oncology | Interview with David O’Malley, MD - a podcast by Dr Neil Love

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr O’Malley on the following topics:

• Emerging efficacy and safety data with and ongoing investigation of tisotumab vedotin in the management of gynecologic cancers (00:00)
• Dual ICI combination regimens under investigation for gynecologic cancers (3:50)
• Clinical care of patients with HER2-positive endometrial cancer (8:39)
• Efficacy and tolerability of pembrolizumab/lenvatinib in patients with microsatellite-stable endometrial cancer (12:01)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love